• Development of selective agonists and antagonists for the human vasoactive intestinal polypeptide VPAC(2) receptor.
Auteur:Moreno, David; Gourlet, Philippe; De Neef, Philippe; Cnudde, Johannes Gary; Waelbroeck, Magali; Robberecht, Patrick
Informations sur la publication:Peptides, 21, 10, page (1543-1549)
Statut de publication:Publié, 2000-10
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Acylation
Adenylate Cyclase -- metabolism
Amino Acid Sequence
Binding, Competitive
CHO Cells
Drug Design
Enzyme Activation -- drug effects
Inhibitory Concentration 50
Molecular Sequence Data
Myristic Acid -- metabolism
Peptide Fragments -- chemical synthesis
Peptide Fragments -- chemistry
Peptide Fragments -- pharmacology
Peptides, Cyclic -- chemical synthesis
Peptides, Cyclic -- chemistry
Peptides, Cyclic -- pharmacology
Receptors, Vasoactive Intestinal Peptide -- agonists
Receptors, Vasoactive Intestinal Peptide -- antagonists & inhibitors
Receptors, Vasoactive Intestinal Peptide -- genetics
Receptors, Vasoactive Intestinal Peptide -- metabolism
Receptors, Vasoactive Intestinal Peptide, Type II
Receptors, Vasoactive Intestinal Polypeptide, Type I
Recombinant Proteins -- agonists
Recombinant Proteins -- antagonists & inhibitors
Substrate Specificity
Vasoactive Intestinal Peptide -- analogs & derivatives
Vasoactive Intestinal Peptide -- chemical synthesis
Vasoactive Intestinal Peptide -- chemistry
Vasoactive Intestinal Peptide -- pharmacology
Vasodilator Agents -- chemical synthesis
Vasodilator Agents -- chemistry
Vasodilator Agents -- pharmacology
Note générale:Journal Article
Research Support, Non-U.S. Gov't